FEDERATION OF CLINICAL IMMUNOLOGY SOCIETIES INC (EIN 760715404) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2002

Legal Domicile

Principal Officer

CALEY MUTRIE

Phone

4143591670

Tax Period

2023-01-01 to 2023-12-31

FEDERATION OF CLINICAL IMMUNOLOGY SOCIETIES INC, founded in 2002, is a community nonprofit in the Diseases & Disorders sector that reported $1.3M in total revenue in fiscal year 2023. Expenses of $1.6M exceeded revenue, resulting in a 26% operating deficit.

Mission

THE MISSION OF THE FEDERATION OF CLINICAL IMMUNOLOGY SOCIETIES (FOCIS) IS TO APPLY THE SCIENCE OF IMMUNOLOGY TO IMPROVE HUMAN HEALTH THROUGH INTERDISCIPLINARY RESEARCH, EDUCATION, COMMUNICATION, AND COLLABORATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $529,050

Program Service Revenue $666,287

Investment Income $81,788

Other Revenue $5,023

TOTAL REVENUE $1,282,148

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $107,683

Program Expenses $1,282,247

Other Expenses $1,614,200

TOTAL EXPENSES $1,614,200

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,282,148	$1,238,728	+0.0%
Expenses	$1,614,200	$1,366,901	+0.2%
Net Income	$-332,052	$-128,173	+1.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

114

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MEGAN SYKES	PRESIDENT	1.00	Officer Director	$0	$0	$0
IGNACIO ANEGON	PRESIDENT-ELECT	1.00	Officer Director	$0	$0	$0
WILLIAM ROBINSON	SECRETARY/TREASURER (FROM 6/23)	1.00	Officer Director	$0	$0	$0
MARK ANDERSON	PAST PRESIDENT	1.00	Officer Director	$0	$0	$0
JONATHAN MALTZMAN	SECRETARY/TREASURER (THRU 6/23)	1.00	Officer Director	$0	$0	$0
JEFFREY RATHMELL	FOCIS CENTERS OF EXCELLENCE CHAIR	1.00	Director	$0	$0	$0
OLIVIER BOYER	MULTINATIONAL FCE CHAIR	1.00	Director	$0	$0	$0
STEPHANIE EISENBARTH	EDUCATION CHAIR	1.00	Director	$0	$0	$0
BETTY DIAMOND	MEMBERSHIP CHAIR	1.00	Director	$0	$0	$0
JOSHUA MILNER	SCIENTIFIC PROGRAM CHAIR (FROM 6/23)	1.00	Director	$0	$0	$0
JANE BUCKNER	AT LARGE DIRECTOR	1.00	Director	$0	$0	$0
TERRI LAUFER	AT LARGE DIRECTOR	1.00	Director	$0	$0	$0
LEONIE TAAMS	AT LARGE DIRECTOR	1.00	Director	$0	$0	$0
LAURENCE TURKA	AT LARGE DIRECTOR	1.00	Director	$0	$0	$0
JANE GROGAN	AT LARGE DIRECTOR	1.00	Director	$0	$0	$0
ROBERT BALDERAS	AT LARGE DIRECTOR (THRU 6/23)	1.00	Director	$0	$0	$0
CALEY MUTRIE	EXECUTIVE DIRECTOR	40.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,282,148	$1,614,200	$2,218,972	$-332,052
2022	$1,238,728	$1,366,901	$2,415,460	$-128,173
2021	$1,102,297	$809,930	$2,741,511	$292,367
2020	$1,428,545	$982,701	$2,311,977	$445,844
2019	$1,643,592	$1,439,633	$2,027,782	$203,959
2018	$2,249,512	$1,932,739	$1,735,113	$316,773

FEDERATION OF CLINICAL IMMUNOLOGY SOCIETIES INC